Cargando…
Immunomodulation for the Treatment of Fungal Infections: Opportunities and Challenges
Opportunistic fungal infections are major causes of morbidity and mortality in patients with single or multiple defects in their immunity. Antifungal agents targeting the pathogen remain the treatment of choice for fungal infections. However, antifungal agents are toxic to the host mainly due to the...
Autor principal: | Ademe, Muluneh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522196/ https://www.ncbi.nlm.nih.gov/pubmed/33042859 http://dx.doi.org/10.3389/fcimb.2020.00469 |
Ejemplares similares
-
Macrophage Mediated Immunomodulation During Cryptococcus Pulmonary Infection
por: Wang, Yan, et al.
Publicado: (2022) -
Emerging Roles of Extracellular Vesicles in Pneumococcal Infections: Immunomodulators to Potential Novel Vaccine Candidates
por: Parveen, Saba, et al.
Publicado: (2022) -
Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy
por: Santos, Emanuelle de Souza, et al.
Publicado: (2021) -
Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections
por: Kischkel, Brenda, et al.
Publicado: (2020) -
Intestinal bacteria—a powerful weapon for fungal infections treatment
por: Cong, Liu, et al.
Publicado: (2023)